Martin Sweeney

1.2k total citations
29 papers, 918 citations indexed

About

Martin Sweeney is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Martin Sweeney has authored 29 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Epidemiology. Recurrent topics in Martin Sweeney's work include Biochemical and Molecular Research (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Martin Sweeney is often cited by papers focused on Biochemical and Molecular Research (8 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Martin Sweeney collaborates with scholars based in United States, Ireland and United Kingdom. Martin Sweeney's co-authors include David H. Hoffman, Gerald A. Poore, Michail A. Esterman, Koert Gerzon, James Ashmore, Donald C. DeLong, Gerald E. Gutowski, Robert L. Hamill, George Weber and Harold P. Morris and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Martin Sweeney

29 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Sweeney United States 17 523 208 156 148 117 29 918
May S. Lui United States 22 857 1.6× 177 0.9× 339 2.2× 187 1.3× 142 1.2× 30 1.2k
Song Feng China 17 359 0.7× 159 0.8× 75 0.5× 170 1.1× 135 1.2× 38 944
Masatoshi Tsujino Japan 10 438 0.8× 222 1.1× 137 0.9× 89 0.6× 61 0.5× 17 705
Christos Papageorgiou Greece 16 451 0.9× 202 1.0× 65 0.4× 83 0.6× 172 1.5× 61 1.0k
Linda L. Wotring United States 22 632 1.2× 684 3.3× 233 1.5× 223 1.5× 131 1.1× 69 1.5k
Robert M. Rydzewski United States 14 628 1.2× 243 1.2× 137 0.9× 725 4.9× 137 1.2× 22 1.5k
Takenori Natori Japan 17 623 1.2× 536 2.6× 21 0.1× 99 0.7× 159 1.4× 36 1.8k
Natalia F. Krynetskaia United States 18 630 1.2× 35 0.2× 40 0.3× 76 0.5× 227 1.9× 28 1.3k
Hans Jörg Hacker Germany 22 516 1.0× 98 0.5× 138 0.9× 569 3.8× 189 1.6× 46 1.5k
T. R. BEATTIE United States 8 340 0.7× 200 1.0× 21 0.1× 51 0.3× 84 0.7× 10 602

Countries citing papers authored by Martin Sweeney

Since Specialization
Citations

This map shows the geographic impact of Martin Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Sweeney more than expected).

Fields of papers citing papers by Martin Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Sweeney. The network helps show where Martin Sweeney may publish in the future.

Co-authorship network of co-authors of Martin Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Sweeney. A scholar is included among the top collaborators of Martin Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Sweeney. Martin Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeney, Martin, et al.. (2021). Advances in the Synthesis of Ring-Fused Benzimidazoles and Imidazobenzimidazoles. Molecules. 26(9). 2684–2684. 24 indexed citations
2.
Sweeney, Martin, Michael P. Carty, Georgia A. Zissimou, et al.. (2018). Anti-Cancer Activity of Phenyl and Pyrid-2-yl 1,3-Substituted Benzo[1,2,4]triazin-7-ones and Stable Free Radical Precursors. Molecules. 23(3). 574–574. 8 indexed citations
4.
Sweeney, Martin, et al.. (2017). Greener synthesis using hydrogen peroxide in ethyl acetate of alicyclic ring-fused benzimidazoles and anti-tumour benzimidazolequinones. Tetrahedron Letters. 58(36). 3565–3567. 9 indexed citations
5.
Sweeney, Martin, Paul Kavanagh, Andrey A. Berezin, et al.. (2016). Discovery of anti-cancer activity for benzo[1,2,4]triazin-7-ones: Very strong correlation to pleurotin and thioredoxin reductase inhibition. Bioorganic & Medicinal Chemistry. 24(16). 3565–3570. 21 indexed citations
6.
Sweeney, Martin, et al.. (2015). One-Pot Hydrogen Peroxide and Hydrohalic Acid Induced Ring Closure and Selective Aromatic Halogenation To Give New Ring-Fused Benzimidazoles. Organic Letters. 17(11). 2856–2859. 16 indexed citations
7.
Jahnke, L. L., et al.. (1989). Anaerobic biosynthesis of unsaturated fatty acids in the cyanobacterium, Oscillatoria limnetica. Archives of Microbiology. 152(3). 215–217. 8 indexed citations
8.
Sweeney, Martin, et al.. (1981). An IgE inhibition assay for the detection of allergen specific IgE.. PubMed. 46(6). 295–300. 3 indexed citations
9.
Sweeney, Martin, George B. Boder, George J. Cullinan, et al.. (1978). Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2886–91. 26 indexed citations
10.
Barnett, Charles J., George J. Cullinan, Koert Gerzon, et al.. (1978). Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate. Journal of Medicinal Chemistry. 21(1). 88–96. 102 indexed citations
11.
Sweeney, Martin. (1977). Mycophenolic acid and its mechanism of action in cancer and psoriasis.. PubMed. 30 Suppl. 85–92. 25 indexed citations
12.
Sweeney, Martin, et al.. (1974). Biosynthesis of uridine-5′-monophosphate in rat liver and morris hepatomas. Advances in Enzyme Regulation. 12. 385–396. 20 indexed citations
13.
Sweeney, Martin, et al.. (1973). Experimental Antitumor Activity of Pyrazomycin. Cancer Research. 33(11). 2619–2623. 64 indexed citations
14.
Hoffman, David H. & Martin Sweeney. (1973). Orotate phosphoribosyl transferase and orotidylic acid decarboxylase activities in liver and Morris hepatomas.. PubMed. 33(5). 1109–12. 10 indexed citations
15.
Sweeney, Martin, David H. Hoffman, & Michail A. Esterman. (1972). Metabolism and biochemistry of mycophenolic acid.. PubMed. 32(9). 1803–9. 110 indexed citations
16.
Esterman, Michail A., Robert W. Johnson, & Martin Sweeney. (1972). Culture of L1210 cells stored at −190 °C. Cryobiology. 9(2). 144–146. 1 indexed citations
17.
Svoboda, Gordon H., et al.. (1971). Antitumor Activity of An Acronycine-Polyvinylpyrrolidone Coprecipitate. Journal of Pharmaceutical Sciences. 60(2). 333–333. 16 indexed citations
18.
Williams, Robert H., et al.. (1968). MYGOPHENOLIG ACID : ANTIVIRAL AND ANTITUMOR PROPERTIES. The Journal of Antibiotics. 21(7). 463–464. 101 indexed citations
19.
Sweeney, Martin, James Ashmore, Harold P. Morris, & George Weber. (1963). COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES.. PubMed. 23. 995–1002. 79 indexed citations
20.
Ashmore, James, Martin Sweeney, Harold P. Morris, & George Weber. (1963). Change from liver-type to muscle-type fructose metabolism in hepatomas. Biochimica et Biophysica Acta. 71. 451–453. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026